<< backUK Cardiovascular Journal Club
Other Seminars/Schedules | Spring 2005 | Fall 2005 |Tuesdays 8:00 a.m. - 9:00 a.m.
Wethington Building, Rm 523
For more information contact: Steve Post, Ph.D.
| Date | Presenter | Title | Citation Link |
|---|---|---|---|
| 09/13 | Steve Post | A central role for JNK in obesity and insulin resistance | Nature, 420, 333-336 (2002) |
| 09/20 | Qingwei Zhao | Blockade of interleukin-12 function by protein vaccination attenuates atherosclerosis. | Circulation. 2005 Aug 16;112(7):1054-62. |
| 09/27 | Zhenheng Guo | Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure. | Nat Med. 2003 12:1506-12 |
| 10/04 | Hong Lu | Aliskiren, a Human Renin Inhibitor, Ameliorates Cardiac and Renal Damage in Double-Transgenic Rats. | Hypertension. 2005;46:569-576 |
| 10/11 | Meredith Bostrom | Macrophage-specific expression of group IIA sPLA2 results in accelerated atherogenesis by increasing oxidative stress. | Journal of Lipid Res. (2005) 46:1604-1614 |
| 10/18 | Jill Cholewa | Expression of Class A Scavenger Receptor Is Enhanced by High Glucose in Vitro and under Diabetic Conditions in Vivo ONE MECHANISM FOR AN INCREASED RATE OF ATHEROSCLEROSIS IN DIABETES*. | JBC (2005) 280, pp. 3355–3364 |
| 10/25 | Sara Police | Production of Chemokines by Perivascular Adipose Tissue: A Role in the Pathogenesis of Atherosclerosis? | ATVB 2005 |
| 11/01 | Rebecca Scotland | The transcriptional repressor Nab1 is a specific regulator of pathological cardiac hypertrophy. | Nat Med. 2005 Aug;11(8):837-44. |
| 11/08 | Fei Huang | Endostatin binds biglycan and LDL and interferes with LDL retention to the subendothelial matrix during atherosclerosis. | J. Lipid Res. 2005.46:1849–1859. |
| 11/15 | No Journal Club - AHA Meetings (Dallas) | ||
| 11/22 | Vishwesh Mokashi | Transcriptional Repression of ATP-Binding Cassette Transporter A1 Gene in Macrophages: A Novel Atherosclerotic Effect of Angiotensin II. | Circ Res. 2005; 97:e88–e96. |
| 11/29 | Julie Oestreich | Clopidogrel inhibits platelet-leukocyte adhesion and platelet dependent leukocyte activation. | Thromb Haemost 2005; 94: 568–77. |
| 11/06 | Phil Owens | Modulation of atheroslcerosis in mice by Toll-like receptor 2. | J. Clin. Invest. 115:3149-3156 (2005). |
